Increasing Knowledge and Interest in Cancer Clinical Trials

July 15, 2025 updated by: Hayley Thompson
This trial investigates how well a video-based clinical trial education session works in increasing knowledge and interest in cancer clinical trials among individuals in the metropolitan Detroit region of the Karmanos Cancer Institute (KCI) catchment area. This educational activity may help researchers learn more about individuals' awareness of clinical trials, knowledge, and intention to participates in a clinical trial.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

PRIMARY OBJECTIVE:

I. To increase cancer clinical trial knowledge and interest through video-based education among individuals aged 21 and older in the metropolitan Detroit region of the KCI catchment area.

OUTLINE:

Participants view educational video consisting of information on the purpose of clinical trials, myths associated with clinical trials, and how to find more information about clinical trials.

Study Type

Interventional

Enrollment (Estimated)

384

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Michigan
      • Detroit, Michigan, United States, 48201
        • Recruiting
        • Wayne State University/Karmanos Cancer Institute
        • Contact:
        • Principal Investigator:
          • Hayley Thompson

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Individuals aged 21 and older
  • Participants will be identified through Karmanos Cancer Institute's (KCI) clinical treatment center
  • Participants will be identified through community-based KCI-sponsored events
  • Participants will have voiced an interest to participate followed by an Informed consent

Exclusion Criteria

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Health Services Research (educational video)
Participants view educational video consisting of information on the purpose of clinical trials, myths associated with clinical trials, and how to find more information about clinical trials.
Other: Web-based Educational Intervention
View web-based educational video
Other Names:
  • Education for Intervention
Other: Questionnaire Administration
Pre video baseline survey and a post video educational survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Increase in Clinical Trial Awareness and Knowledge
Time Frame: Baseline and immediately post intervention up to 1 day
An 11-question true and false questionnaire regarding Knowledge will be administered prior to and immediately after a video-based educational session on Clinical Trials
Baseline and immediately post intervention up to 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Increase in intentions to participate in cancer clinical trials.
Time Frame: Baseline and immediately post intervention up to 1 day
A 6-question standard Likert scale questionnaire regarding Intention will be administered prior to and immediately after a video-based educational session on Clinical Trials.
Baseline and immediately post intervention up to 1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hayley Thompson

Collaborators

National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Hayley Thompson, Barbara Ann Karmanos Cancer Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 12, 2020

Primary Completion (Estimated)

February 1, 2026

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

May 3, 2024

First Submitted That Met QC Criteria

July 11, 2024

First Posted (Actual)

July 15, 2024

Study Record Updates

Last Update Posted (Actual)

July 16, 2025

Last Update Submitted That Met QC Criteria

July 15, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-137 (Other Identifier: Wayne State University/Karmanos Cancer Institute)
  • P30CA022453 (U.S. NIH Grant/Contract)
  • NCI-2020-07119 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hematopoietic and Lymphoid Cell Neoplasm

Clinical Trials on Web-based Educational Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe